- Category
- Small (2020-21)
- Udyam number
- UDYAM-RJ-02-0008879

About Shree Nath Life Sciences Private Limited
Data last updated:
Shree Nath Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 11 November 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2004PTC130543. Its GSTIN is 08AAICS9934N1ZG (Rajasthan). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.3 Lakh. It is led by directors Ravinder Kumar Gupta and Shubham Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1702 – 03/102 1st Floor Shrinath Market Bhagirath Palace, Delhi, India – 110006.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.39 Cr, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹2.03 Cr (net margin 5.4%) and EBITDA of ₹5.14 Cr (EBITDA margin 13.8%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 5% over five years.
The company has about 72 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5.45 Cr and satisfied charges of ₹1.73 Cr on record.
Shree Nath Life Sciences Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-02-0008879). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shreenathlife.com.
Company details
Recognitions & Rankings of Shree Nath Life Sciences
Contact details
Shree Nath Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is shreenathlife.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address1702 – 03/102 1st Floor Shrinath Market Bhagirath Palace, Delhi, India – 110006
- IndustryPharma, API Manufacturers
To see the full contact details of Shree Nath Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Shree Nath Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Shree Nath Life Sciences Private Limited, buy the company report.
Financials of Shree Nath Life Sciences Private Limited
FY 2025 filings availableShree Nath Life Sciences Private Limited reported revenue of ₹37.39 Cr (down 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 28% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 44% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.14 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.03 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.8% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shree Nath Life Sciences Private Limited, buy the company report.
Board of directors of Shree Nath Life Sciences Private Limited
Shree Nath Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravinder Kumar Gupta Also directs: Jay Vee Overseas LLP, SNL Urbane Infra LLP | Director | 11 Nov 2004 | 21 Years 11 Months | Current |
| Shubham Gupta Also directs: SNL Urbane Infra LLP | Director | 21 Nov 2017 | 8 Years 11 Months | Current |
Peer comparison
Shree Nath Life Sciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vadivarhe Speciality Chemicals Limited | ₹38.17 Cr (FY 2025) | -6.0% | Igatpuri, Maharashtra, India | |||
| Ad-Pharmachem Private Limited | ₹37.8 Cr (FY 2024) | -15.0% | Aurangabad, Maharashtra, India | |||
| Ceyone Life Sciences Private Limited | ₹37.68 Cr (FY 2025) | 63.0% | Anakapalle, Andhra Pradesh, India | |||
| Auroactive Pharma Private Limited | ₹37.55 Cr (FY 2025) | 8244.0% | Hyderabad, Telangana, India | |||
| Shree Nath Life Sciences Private Limitedthis company | ₹37.39 Cr (FY 2025) | ₹2.03 Cr | 5.4% | -28.0% | 72 | Delhi, India |
| Nira Life Sciences Private Limited | ₹37.1 Cr (FY 2024) | -18.0% | Rajkot, Gujarat, India | |||
| Nandesari Drugs and Pharmaceuticals Private Limited | ₹37.08 Cr (FY 2024) | 1417.0% | Delhi, India | |||
| Globela Industries Private Limited | ₹37.05 Cr (FY 2025) | -2.0% | Vagra, Gujarat, India | |||
| Chempro Pharma Private Limited | ₹37.02 Cr (FY 2025) | -12.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Shree Nath Life Sciences Private Limited, buy the company report.
Auditor
Shree Nath Life Sciences Private Limited is audited by S P M S & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S P M S & ASSOCIATES | FY 2023 | 015808N |
Shareholding
The shareholding of Shree Nath Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Shree Nath Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Feb 2024 | 100862676 | Others | ₹50 Lakh | Open | |
| 21 Dec 2016 | 100069835 | Axis Bank Limited | ₹4.95 Cr | Open | |
| 03 Dec 2010 | 10255201 | Bank of India | ₹1.73 Cr | Satisfied |
To see the full charge records of Shree Nath Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Shree Nath Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shree Nath Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Shree Nath Life Sciences Private Limited has a workforce of 72 employees on its EPFO records as of Apr 08, 2024, across 2 active EPFO establishments.
GST
Shree Nath Life Sciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAICS9934N1ZG | Rajasthan | Active | 01 Jul 2017 |
| 08AAICS9934N2ZF | Rajasthan | Active | 30 Oct 2020 |
To see the full GST registrations and return filing status of Shree Nath Life Sciences Private Limited, buy the company report.
Recent activity
Shree Nath Life Sciences Private Limited has 4 board changes on record since 2004: 2 appointments and 2 cessations. The latest: Vijay Kumar Gupta ceased to be Director on 10 Feb 2018.
1 earlier event is in the company report.
Frequently asked questions
Shree Nath Life Sciences is an active private limited company based in Delhi, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 11 November 2004 (22+ years old) and is registered under CIN U24239DL2004PTC130543.
Shree Nath Life Sciences has 2 current directors:
- Ravinder Kumar Gupta - Director
- Shubham Gupta - Director
The latest financial statements of Shree Nath Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Shree Nath Life Sciences is 08AAICS9934N1ZG, registered in Rajasthan. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 08AAICS9934N2ZF (Rajasthan).
The CIN (Corporate Identification Number) of Shree Nath Life Sciences is U24239DL2004PTC130543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shree Nath Life Sciences was incorporated on 11 November 2004, making it 22+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Shree Nath Life Sciences by revenue are Vadivarhe Speciality Chemicals Limited, Ad-Pharmachem Private Limited, Ceyone Life Sciences Private Limited, Auroactive Pharma Private Limited, Nira Life Sciences Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vijay Kumar Gupta ceased to be Director on 10 Feb 2018. Shubham Gupta was appointed as Director on 21 Nov 2017. Renu Gupta ceased to be Director on 10 May 2009. Shree Nath Life Sciences has 4 board changes on record in total.
Yes, Shree Nath Life Sciences is registered as a small enterprise under Udyam registration (number: UDYAM-RJ-02-0008879).
Shree Nath Life Sciences can be reached through the website shreenathlife.com. Its registered office is in Delhi, India.
The registered office of Shree Nath Life Sciences is at 1702 – 03102 1st Floor Shrinath Market Bhagirath Palace, Delhi, India – 110006.